-transparent.png){kind=logo}
Urokinase plasminogen activator and its receptor are both found at the surface of the cell membrane in many cell types. The plasminogen activator inhibitor type-1 (PAI-1) is often associated with the extracellular matrix. The spatial localization of these three molecules could account for their involvement in cell adhesion and/or migration. We have shown previously that the urokinase receptor mediates mechanical force transmission across the cell surface to the cytoskeleton. Here we investigated whether immobilized plasminogen activator inhibitor type 1 (PAI-1) could regulate cell spreading and cytoskeleton reorganization. Serum deprived human myogenic cells were plated in serum free medium onto bacteriologic dishes precoated with different extracellular matrix ligands (fibronectin, vitronectin, or type 1 collagen) or PAI-1 at increasing concentrations. The number of adherent cells and their projected area were quantitated after 3 hours of plating. PAI-1 promoted cell adhesion and spreading in a dose dependent manner. Addition of antibodies to PAI-1 inhibited the adhesion on PAI-1 coated dishes in a dose dependent way. The PAI-1 mediated cell adhesion required the presence of urokinase at the cell surface. Removal of the glycosylphosphatidylinositol (GPI)-linked proteins abolished cell adhesion on PAI-1 dish, suggesting its dependence on the presence of the urokinase receptor, a GPI-linked receptor. Furthermore, addition of antibodies against alpha v beta3 integrin completely inhibited cell adhesion on PAI-1, suggesting that alpha v beta3 might be the transmembrane molecule that physically connects the complex of PAI-1, urokinase, and urokinase receptor to the cytoskeleton. Visualization of spread cells stained for filamentous actin with confocal microscopy showed a dose-dependent increase of filopodia on PAI-1 coated dishes and cytoskeletal reorganization, suggesting a migratory profile. These data indicate that PAI-1 plays a direct role in dynamic cell adhesion particularly at the leading edge, where increased levels of urokinase plasminogen activator (uPA) and its receptor (uPAR) are localized in migrating cells. Immobilized PAI-1 could therefore serve to bridge the cell surface with the extracellular matrix via the formation of a multimolecular complex that includes alpha v beta3 integrins in myogenic cells.
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
January 1997,
Oncology reports,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
June 1995,
Journal of cell science,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
October 1995,
European journal of biochemistry,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
May 2000,
Pathology international,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
September 1995,
The Journal of biological chemistry,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
April 2007,
Lung cancer (Amsterdam, Netherlands),
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
July 1989,
Proceedings of the National Academy of Sciences of the United States of America,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
September 1994,
European journal of biochemistry,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
January 1995,
Japanese journal of cancer research : Gann,
E Planus, and
G Barlovatz-Meimon, and
R A Rogers, and
S Bonavaud, and
D E Ingber, and
N Wang
January 1994,
Cancer research,
